16 results on '"Hansen, Timon"'
Search Results
2. Diagnosing AL and ATTR Amyloid Cardiomyopathy: A Multidisciplinary Approach.
3. Long-term evaluation of amyloidosis diseases in Germany: National Clinical Amyloidosis Registry
4. Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p
5. Living with the burden of relapse in multiple myeloma from the patient and physician perspective
6. Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
7. Two-Year Evaluation of the German Clinical Amyloidosis Registry
8. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
9. Daratumumab, lenalidomide, and dexamethasone in systemic light‐chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21
10. Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria
11. Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)
12. Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies
13. Amyloidose: Einführung und Diagnostik
14. Prognose und Therapie der AL-Amyloidose
15. The Finding of Del 17p in Marrow Plasma Cells from Patients with Light-Chain Amyloidosis (AL) May Confer a Worse Prognosis
16. In der Erstlinie verlängert Lenalidomid/Dexamethason bis zum Progress das Überleben von Myelompatienten
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.